Clementine Calba

  • Clementine Calba works at Santé Publique France, particularly within the Direction des Régions. She plays a key role in regional public health management, focusing on the implementation of epidemiological surveillance and health risk prevention strategies. Her work involves addressing regional health challenges, especially those related to infectious diseases and environmental health risks. Through this position, she ensures the alignment of public health measures with local needs, contributing to the broader public health landscape in France

  • Increased risk of arboviruses transmission in mainland France: how do we deal with this new paradigm?

    Aedes albopictus, a mosquito species known to transmit dengue, chikungunya, and Zika viruses, is established in mainland France since 2004. Since then, its distribution has considerably expanded, increasing the risk of local transmission of these viruses. Epidemiological surveillance of imported and autochthonous cases of these three arboviruses relies on mandatory notification. From May to November, this surveillance is enhanced to prevent or limit local transmission: healthcare professionals are encouraged to diagnose and report cases, active case finding is performed through daily monitoring of major laboratory platforms and cases are investigated to guide vector control measures. In the event of autochthonous transmission (at least one case with no travel history in an area known for arbovirus circulation), door-to-door case finding is conducted, awareness campaigns are reinforced among healthcare professionals and the general population, and extensive vector control measures are carried out around cases. To date, the surveillance system has proved effective in detecting and reducing local transmission: between 2010 and 2024, 48 dengue events (242 cases), four chikungunya events (32 cases), and one Zika event (3 cases) were detected. Most of these local transmissions remained in a limited perimeter (median diameter of 150m) with a limited number of cases (max. 35 cases). However, more than 70% of autochthonous cases were reported between 2022 and 2024. The increase since 2022 in the number and intensity of local transmissions of dengue in mainland France threatens the surveillance and response system. This dynamic has raised fears of an epidemic, which could overwhelm the system in the coming years. In a context where public health resources are limited or even reduced, work is underway on prioritising interventions and mobilising external resources. Decision makers need to be ready for action to meet the challenges raised by this new paradigm.

Romeo Bellini

    • Romeo Bellini is former Director of the Sanitary Entomology & Zoology Department at the Centro Agricoltura Ambiente (CAA) “G. Nicoli” in Italy and former leads of the IAEA Collaborating Centre. He has 35 years of experience in mosquito ecology and control. His research focuses on mosquito surveillance and innovative control strategies, such as the Sterile Insect Technique (SIT), particularly for Aedes species. He has participated in EU projects under LIFE, FP7, and Horizon 2020 programs. He has also served as a director for the Society for Vector Ecology and the European Mosquito Control Association. He provides expert consultations to international bodies like WHO, ECDC, EFSA, and IAEA.

  • The sterile insect technique against Aedes mosquitoes: An update

    The increasing evidence on the negative effects of insecticides including the widespread resistance developed by target vector populations against the most used active ingredients, are requiring the development of new control methods to be deployed against mosquitoes. Among the proposed possibilities, the genetic control-based methods are finding large interest for their high species specificity assuring very low environmental and public health impact. The sterile insect technique (SIT) is a well-established technology, included in the biological control methods, successfully applied area-wide since decades to suppress/eliminate many agricultural pest species. Since the early 2000, the International Atomic Energy Agency, following the strong demand by member states, has started a programme to develop SIT against mosquito vectors of diseases, mainly Aedes aegypti, Ae. albopictus and also Anopheles spp. Mass rearing new technologies are under development to support the production process; sex sorting methods exploiting dimorphism are currently used on the pupal or adult stage; optimal male sub-sterilisation level is achieved by irradiation with gamma or X ray; quality control procedures are proposed to assist the production of vigorous sterile males; ground and aerial release systems are under testing to assure optimal sterile males distribution; methods to measure the entomological and the epidemiological effectiveness are made available. An important issue on the way of area-wide SIT application against mosquitoes remains the cost which should be reduced to make the technology more affordable and sustainable.

Sophie Vanwambeke

    • Sophie Vanwambeke is a medical geographer, who graduated with a PhD in Sciences (geography) in 2005 in UCLouvain. She is a professor in the School of Geography and Earth & Life Institute in UCLouvain. Her research focuses on the geography of infectious diseases as a manifestation of spatial interactions between human societies and their environment. She has worked on mosquito-, tick- and rodent-borne diseases in temperate and tropical regions, both in the field of human and animal health

  • Land systems governance and vector-borne diseases

    The effect of land use and land cover on vector-borne diseases has been conceptualised in various forms, ranging from Pavlovsky’s nidality of diseases, pathogenic landscapes or more recently, in a different perspective, landscape immunity. In this context, land cover has been used widely as a proxy for vector and host habitat and as such often assumed to help monitor hazard (as abundance of infected vectors). Land use, which includes dimensions related to human activities and what land cover is effectively used as by human societies, has provided additional insight into exposure to infected vectors. The land system framework, as it has been elaborated in the field of land science, has added multiple layers to our understanding of what shapes landscapes. Prominent features of interest in the context of vector-borne as well as zoonotic diseases include land legacies, inequities, trade-offs, the role of institutions and distant causes. Very superficially, one could say that land systems examine more broadly the elements shaping landscapes at various spatial, temporal and institutional scales, accounting for the diverse priorities stakeholders may have. For instance, the land system framework acknowledges that landscapes reflect decisions made over decades, if not centuries and as such cannot be easily steered in other directions. Looking into distant causes allows to understand factors affecting land management beyond the “farm gate”. The full potential of this framework has not been explored in the context of health, despite its attention for trade-offs in relation to e.g. conservation. Urbanisation trajectories in the Western world have created extensive and complex ecological interfaces between human-inhabited built-up areas and natural or semi-natural habitats supporting wildlife, whose role in conservation in increasingly emphasised. This may create landscapes that support tick- and mosquito-borne diseases. Agricultural development trajectories in the tropics may have increased the susceptibility of livestock and human populations to vector-borne diseases. We argue that, if land is to be one of the levers into more proactive management of vector-borne and zoonotic disease risk, in a One Health spirit, the land systems framework offers a meaningful tool to understand how landscapes are shaped and may change in the future, and what drives decision and may constraint health risk management when land is concerned. Furthermore, unintended consequences should be assessed when decisions affecting land are taken. The potential reinforcement of integrating health in the land systems framework would thus be beneficial both for health risk management and for sustainable land use decision-making

Derric Nimmo

    • Derric Nimmo is Director of Technical Development at IVCC and manages the IVCC technical team and portfolio, evaluating new active ingredients and innovative vector control tools. The technical team works with industry and academic partners to bring innovative and sustainable tools for vector control to the market. Derric has 25 years of experience in molecular entomology and field research with various insect disease vectors. IVCC is the only Product Development Partnership focused on solutions for vector control. IVCC partners with stakeholders across industry, scientific institutions, and endemic countries to facilitate and accelerate the development and availability of novel and improved public health insecticides and formulations that can combat the rapidly growing problem of insecticide resistance.

  • Supporting innovation to encourage the development of novel approaches to enhance vector control.

    Vector control contributes to over 70% of the reduction in malaria burden. Developing innovative products in a resource-constrained and challenged market requires significant investment in resources, expertise, and funding. IVCC is the only product development partnership (PDP) in vector control, collaborating with academic, field facilities, and industry partners to develop, register and introduce to the market new active ingredients and innovative approaches to vector control, focusing on insecticide-treated nets (ITNs), indoor residual spraying (IRS), spatial emanators, and interventions to reduce outdoor transmission. IVCC works with partners to explore opportunities and tackle the significant challenges of product development, registration and market access. The IVCC PDP model strengthens laboratories and field facilities in the UK, Africa, and the Indo-Pacific to support partners with the testing, evaluation, and expertise needed to advance vector control products through development. Since 2007, our industry partners have screened their libraries with around 4.5 million chemical compounds, identifying 27 chemical classes with novel modes of action for use in public health. Of these chemical classes, several novel active ingredients continue to be investigated today as part of our development portfolio. Once lead candidates have been identified, they will become part of a broader portfolio of existing and repurposed chemistry for use in vector control tools. Insecticide Resistance Management (IRM) is key if these novel active ingredients are sustainable in the market and successfully combat insecticide resistance. The recent introduction of Interceptor® G2 from BASF, supported by IVCC, is an excellent example of how a new product can be successfully developed, registered, introduced to the market and impact insecticide-resistant mosquito populations. The development and access to these innovative new tools contribute to the ongoing effort to develop integrated vector management strategies that are both environmentally sound and effective in reducing the burden of vector-borne diseases.